These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 36035124)

  • 41. Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review.
    Li XL; Sui JQ; Lu LL; Zhang NN; Xu X; Dong QY; Xin YN; Xuan SY
    Lipids Health Dis; 2016 Mar; 15():53. PubMed ID: 26965314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk.
    Athyros VG; Boutari C; Stavropoulos K; Anagnostis P; Imprialos KP; Doumas M; Karagiannis A
    Curr Vasc Pharmacol; 2018; 16(3):246-253. PubMed ID: 28676019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Link Between Non-Alcoholic Fatty Liver Disease and Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Minhas AM; Usman MS; Khan MS; Fatima K; Mangi MA; Illovsky MA
    Cureus; 2017 Apr; 9(4):e1142. PubMed ID: 28484681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease.
    Corey KE; Kartoun U; Zheng H; Chung RT; Shaw SY
    Am J Gastroenterol; 2016 May; 111(5):671-6. PubMed ID: 26925881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
    Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.
    Maliakkal BJ
    Transl Gastroenterol Hepatol; 2020; 5():36. PubMed ID: 32632387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.
    Käräjämäki AJ; Hukkanen J; Ukkola O
    Ann Med; 2018 Aug; 50(5):371-380. PubMed ID: 29929399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of non-alcoholic fatty liver disease in cardiovascular disease.
    Perseghin G
    Dig Dis; 2010; 28(1):210-3. PubMed ID: 20460913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk.
    Delgado GE; Kleber ME; Moissl AP; Yazdani B; Kusnik A; Ebert MP; März W; Krämer BK; Lammert A; Teufel A
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G252-G261. PubMed ID: 34132110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review.
    Stahl EP; Dhindsa DS; Lee SK; Sandesara PB; Chalasani NP; Sperling LS
    J Am Coll Cardiol; 2019 Mar; 73(8):948-963. PubMed ID: 30819364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
    Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between nonalcoholic fatty liver disease and cardiovascular disease revealed after comprehensive control of metabolic risk factors: a nationwide population-based study in Korea.
    Seo BS; Roh JH; Lee JH; Lee H; Min Kim Y; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e375-e382. PubMed ID: 33731579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients.
    Kim K; Kang K; Sheol H; Shin J; Sim Y; Yang T; Hwang J; Lee JM
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.
    Ichikawa K; Miyoshi T; Osawa K; Miki T; Toda H; Ejiri K; Yoshida M; Nanba Y; Yoshida M; Nakamura K; Morita H; Ito H
    Cardiovasc Diabetol; 2021 Jan; 20(1):8. PubMed ID: 33413363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective.
    Ramadan MS; Russo V; Nigro G; Durante-Mangoni E; Zampino R
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33917867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-Alcoholic Fatty Liver Disease and Vascular Disease.
    Forlano R; Mullish BH; Nathwani R; Dhar A; Thursz MR; Manousou P
    Curr Vasc Pharmacol; 2021; 19(3):269-279. PubMed ID: 32188385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study.
    Sinn DH; Kang D; Chang Y; Ryu S; Gu S; Kim H; Seong D; Cho SJ; Yi BK; Park HD; Paik SW; Song YB; Lazo M; Lima JA; Guallar E; Cho J; Gwak GY
    Gut; 2017 Feb; 66(2):323-329. PubMed ID: 27599521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems.
    Kweon YN; Ko HJ; Kim AS; Choi HI; Song JE; Park JY; Kim SM; Hong HE; Min KJ
    Healthcare (Basel); 2021 Jul; 9(7):. PubMed ID: 34356275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
    Johnston MP; Patel J; Byrne CD
    Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
    Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
    J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.